The Association of Prediagnostic Statin Use with Aggressive Prostate Cancer from the Multiethnic Cohort Study.

Fei ChenPeggy WanLynne R WilkensLoïc Le MarchandChristopher A Haiman

Published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2022)

Our findings provide further support for the potential benefits of statins in reducing the risk and mortality of prostate cancer, especially aggressive disease.

Keyphrases

prostate cancer
radical prostatectomy
cardiovascular disease
cardiovascular events
coronary artery disease
type diabetes
risk assessment
climate change
low density lipoprotein